ACCESS Newswire·Nov 9, 2026, 9:00 AM ET

Modular Medical Completes Comprehensive Patient Market Research Study with Thrivable, Reinforcing Strong Interest in Simplified Insulin Delivery

Modular Medical announced completion of a three-phase market research study involving more than 540 Type 1 & Type 2 diabetes participants regarding the Pivot tubeless patch pump.
90% of multiple daily injection (MDI) users expressed openness to a simpler insulin delivery method.
83% of high-burden participants indicated they would discuss Pivot as an option with their healthcare provider.
48.5% of final-phase participants (n=303) expressed strong interest in the Pivot system.
The study included 230 participants in Phase 1, 20 in-depth interviews, & over 300 MDI users in the final survey phase.
CGM usage ranged from 75% to 90% across all study cohorts.
41.8% of pump-naïve participants cited lack of healthcare provider recommendation as the primary reason for not adopting pump therapy.
Lower cost (59.7%) & reduced effort (57.4%) were identified as the top motivators for MDI users to consider alternative delivery methods.
85.1% of Type 2 respondents expressed strong interest in Pivot prior to detailed messaging, compared to 53.6% of Type 1 respondents.
54.1% of participants cited device attachment security during daily activities as a top information need.
Modular Medical is preparing for the full commercial launch of the Pivot system following this patient-centric insights generation.